GlaxoSmithKline on Monday said it was taking a stake in German vaccines maker CureVac, the latest move by a major drugmaker to boost capabilities to fight pandemics.
GlaxoSmithKline on Monday said it was taking a stake in German vaccines maker CureVac, the latest move by a major drugmaker to boost capabilities to fight pandemics.